RUSSO, VINCENZO
 Distribuzione geografica
Continente #
EU - Europa 17.248
AS - Asia 8.371
NA - Nord America 7.183
SA - Sud America 1.398
Continente sconosciuto - Info sul continente non disponibili 592
AF - Africa 97
OC - Oceania 6
AN - Antartide 1
Totale 34.896
Nazione #
RU - Federazione Russa 12.634
US - Stati Uniti d'America 6.972
SG - Singapore 3.047
CN - Cina 1.754
IE - Irlanda 1.586
HK - Hong Kong 1.411
BR - Brasile 1.163
VN - Vietnam 1.049
IT - Italia 671
GB - Regno Unito 536
DE - Germania 512
FR - Francia 409
KR - Corea 350
UA - Ucraina 252
IN - India 235
SE - Svezia 149
GR - Grecia 122
AR - Argentina 101
FI - Finlandia 98
CA - Canada 88
JP - Giappone 83
TR - Turchia 69
AT - Austria 66
MX - Messico 62
BD - Bangladesh 58
NL - Olanda 48
ID - Indonesia 47
EC - Ecuador 41
AE - Emirati Arabi Uniti 38
PL - Polonia 36
IQ - Iraq 34
CZ - Repubblica Ceca 26
BE - Belgio 24
SA - Arabia Saudita 24
PK - Pakistan 23
ZA - Sudafrica 23
CO - Colombia 22
TH - Thailandia 22
PY - Paraguay 20
UZ - Uzbekistan 18
ES - Italia 17
MA - Marocco 16
EG - Egitto 15
VE - Venezuela 15
JO - Giordania 13
PH - Filippine 12
CL - Cile 11
CR - Costa Rica 11
JM - Giamaica 11
CH - Svizzera 10
PE - Perù 10
LT - Lituania 9
MY - Malesia 9
DO - Repubblica Dominicana 8
HN - Honduras 8
IL - Israele 8
LB - Libano 8
UY - Uruguay 8
AL - Albania 7
NP - Nepal 7
OM - Oman 7
TN - Tunisia 7
BO - Bolivia 6
ET - Etiopia 6
KE - Kenya 6
NI - Nicaragua 6
PT - Portogallo 6
RO - Romania 6
SN - Senegal 6
BG - Bulgaria 5
DZ - Algeria 5
QA - Qatar 5
AU - Australia 4
AZ - Azerbaigian 4
CI - Costa d'Avorio 4
EU - Europa 4
IR - Iran 4
KG - Kirghizistan 4
PA - Panama 4
PS - Palestinian Territory 4
AM - Armenia 3
BB - Barbados 3
BH - Bahrain 3
HU - Ungheria 3
KZ - Kazakistan 3
RS - Serbia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
BY - Bielorussia 2
CY - Cipro 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
LK - Sri Lanka 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
Totale 34.287
Città #
Moscow 4.557
Dublin 1.583
Hong Kong 1.389
Singapore 1.299
Santa Clara 1.184
San Jose 884
Chandler 506
Ashburn 493
Jacksonville 465
Hefei 382
Seoul 346
Ho Chi Minh City 335
Hanoi 246
Princeton 228
Dallas 220
The Dalles 209
Roxbury 190
Beijing 185
Bengaluru 157
Bremen 130
Medford 123
Cambridge 115
Naples 105
São Paulo 96
Munich 91
Da Nang 81
Los Angeles 79
New York 75
Ann Arbor 74
Wilmington 70
Boardman 69
Nuremberg 64
Council Bluffs 54
Des Moines 52
San Mateo 48
Haiphong 47
Atlanta 42
Falkenstein 38
Orem 37
Caserta 36
Belo Horizonte 35
Woodbridge 34
Mexico City 31
Vienna 29
Rio de Janeiro 27
Rome 27
Warsaw 27
Guangzhou 26
Jinan 26
Tokyo 26
Brussels 24
Changsha 24
London 24
Chicago 23
Frankfurt am Main 23
Amsterdam 22
Phoenix 22
Brooklyn 21
Memphis 21
Tianjin 21
Aversa 20
Brno 20
San Francisco 20
Chennai 19
Houston 19
Manchester 19
Milan 19
Montreal 19
Bắc Ninh 18
Guarulhos 18
Shanghai 18
Shenyang 18
Stockholm 18
Hải Dương 17
Lappeenranta 17
Turku 17
Zhengzhou 17
Columbus 16
Curitiba 16
Tashkent 16
Porto Alegre 15
Boston 14
Hangzhou 14
Helsinki 14
Lusciano 14
Nanchang 14
Nanjing 14
Toronto 14
Yan Ta Khao 14
Biên Hòa 13
Florence 13
Guayaquil 13
Mumbai 13
Philadelphia 13
Amman 12
Brasília 12
Denver 12
Dhaka 12
Düsseldorf 12
Ercolano 12
Totale 17.522
Nome #
2022 HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders 275
ACE inhibition to slow progression of myocardial fibrosis in muscular dystrophies 168
Short-duration head-up tilt test potentiated with sublingual nitroglycerin in suspected vasovagal syncope: the fast Italian protocol 166
Ambulatory dynamic Holter monitoring: a practical guide to appropriate use and reporting in clinical cardiology 166
Effect of weight loss following bariatric surgery on myocardial dispersion of repolarization in morbidly obese patients. 161
A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience 159
P-wave duration and dispersion in patients with Emery-Dreifuss muscular dystrophy. 153
Efficacy and safety of dabigatran in a "real-life" population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registry 152
Regional and transmural dispersion of repolarisation in patients with Emery-Dreifuss muscular dystrophy. 150
Increased heterogenity of ventricular repolarization in obese nonhypertensive children 148
Apixaban in a morbid obese patient with atrial fibrillation: A clinical experience using the plasmatic drug evaluation 148
Add-on Therapy With Sacubitril/Valsartan and Clinical Outcomes in CRT-D Nonresponder Patients 148
Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: The T.O.S.CA. Registry 148
Arrhythmic CArdiac DEath in MYotonic dystrophy type 1 patients (ACADEMY 1) study: the predictive role of programmed ventricular stimulation 147
Right atrial appendage versus Bachmann's bundle stimulation: a two-year comparative study of electrical parameters in myotonic dystrophy type-1 patients. 147
Acute myocarditis: prognostic role of speckle tracking echocardiography and comparison with cardiac magnetic resonance features 147
Arrhythmias and sudden cardiac death in beta-thalassemia major patients: Noninvasive diagnostic tools and early markers 145
Does a high percentage of right ventricular pacing influence the incidence of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients? 142
Vasovagal Syncope at Work: A Narrative Review for an Occupational Management Proposal 141
Are there real benefits to implanting cardiac devices in patients with end-stage dilated dystrophinopathic cardiomyopathy? Review of literature and personal results 141
Does Bachmann's bundle pacing prevent atrial fibrillation in myotonic dystrophy type 1 patients? A 12 months follow-up study 140
Worsening of cardiomyopathy using deflazacort in an animal model rescued by gene therapy 140
Adenosine-induced sinus tachycardia in a patient with Myotonic Dystrophy type 1. 140
The Lipid-Lowering Efficacy of a Nutraceutical Combination Including Leucoselect Phytosome, Red Yeast Rice, Policosanol and Folic Acid in Dyslipidaemia Patients: Real-World Insights 139
The effect of atrial preference pacing on atrial fibrillation electrophysiological substrate in Myotonic Dystrophy type 1 population. 139
Which hemodynamic parameter predicts nitroglycerin-potentiated head-up tilt test response? 138
Early onset of cardiomyopathy and primary prevention of sudden death in X-linked Emery-Dreifuss muscular dystrophy. 138
Anti-Inflammatory and Anticancer Effects of Anticoagulant Therapy in Patients with Malignancy 137
Paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: P wave duration and dispersion analysis. 137
Dispersion of repolarization and beta-thalassemia major: the prognostic role of QT and JT dispersion for identifying the high-risk patients for sudden death 137
The effect of atrial preference pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: a prospective, randomized, single-bind cross-over study. 137
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 135
Anti-arrhythmic drug therapy in implantable cardioverter-defibrillator recipients 135
DUAL PATHWAY INHIBITION WITH RIVAROXABAN AND ASPIRIN REDUCES INFLAMMATORY BIOMARKERS IN ATHEROSCLEROSIS 134
The main determinant of hypotension in nitroglycerine tilt-induced vasovagal syncope. 134
Optimal site for atrial lead implantation in myotonic dystrophy patients: the role of Bachmann's Bundle stimulation 134
An Update on Betrixaban, the Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis 133
The Impact of Selection Criteria of Obese Patients on Evaluation of Heart Rate Variability Following Bariatric Surgery Weight Loss 133
Arrhythmogenic Left Ventricular Cardiomyopathy: From Diagnosis to Risk Management 132
Coronary sinus spasm during left ventricular lead implantation for biventricular pacing 132
Sympathovagal balance analysis in idiopathic postural orthostatic tachycardia syndrome. 131
A Systematic Review and Meta-analysis of the Association Between Implantable Cardioverter-Defibrillator Shocks and Long-term Mortality 131
The effect of dual-chamber closed-loop stimulation on syncope recurrence in healthy patients with tilt-induced vasovagal cardioinhibitory syncope: a prospective, randomised, single-blind, crossover study. 129
Arrhythmic risk evaluation in myotonic dystrophy: the importance of selection criteria and methodological approach 129
Right atrial preference pacing algorithm in the prevention of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: a long term follow-up study. 128
Increased heterogeneity of ventricular repolarization in myotonic dystrophy type 1 population 128
Ginkgo biloba: an ancient tree with new arrhythmic side effects. 127
A Prospective Study to Evaluate the Effectiveness of Edoxaban for the Resolution of Left Atrial Thrombosis in Patients with Atrial Fibrillation 127
Atrial fibrillation burden in Myotonic Dystrophy type 1 patients implanted with dual chamber pacemaker: the efficacy of the overdrive atrial algorithm at 2 year follow-up. 126
Far field R-wave sensing in Myotonic Dystrophy type 1: right atrial appendage versus Bachmann's bundle region lead placement. 126
Remote monitoring of implantable cardiac monitors in patients with unexplained syncope: Predictors of false‐positive alert episodes 125
Antioxidant Properties of Oral Antithrombotic Therapies in Atherosclerotic Disease and Atrial Fibrillation 125
Advances in the Insulin-Heart Axis: Current Therapies and Future Directions 125
Device-Related Complications and Inappropriate Therapies Among Subcutaneous vs. Transvenous Implantable Defibrillator Recipients: Insight Monaldi Rhythm Registry 125
Early onset "electrical" heart failure in myotonic dystrophy type 1 patient: the role of ICD biventricular pacing. 125
Which parameters describe the electrophysiological properties of successful slow pathway RF ablation in patients with common atrioventricular nodal reentrant tachycardia? 125
Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study 125
Effects of Heart Failure Therapies on Atrial Fibrillation: Biological and Clinical Perspectives 124
Appropriate ICD Interventions for Ventricular Arrhythmias Are Predicted by Higher Syntax Scores I and II in Patients with Ischemic Heart Disease 123
Advances in Nanomedicine for Precision Insulin Delivery 122
Myocardial Work Efficiency in Physiologic Left Ventricular Hypertrophy of Power Athletes 121
Air entrapment as a cause of S-ICD inappropriate shocks 121
Effects of High Intensity Interval Training Rehabilitation Protocol after an Acute Coronary Syndrome on Myocardial Work and Atrial Strain 121
The effect of aortic coarctation surgical repair on QTc and JTc dispersion in severe aortic coarctation newborns: a short-term follow-up study. 120
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 120
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 119
Relationship Between Left Atrial Strain and Atrial Fibrillation: The Role of Stress Echocardiography 118
Superior vena cava thrombosis after intravascular AICD lead extraction: a case report 117
Biventricular pacing and heterogeneity of ventricular repolarization in heart failure patients 117
Biventricular dysfunction and lung congestion in athletes on anabolic androgenic steroids: a speckle tracking and stress lung echocardiography analysis 117
TAKOTSUBO CARDIOMYOPATHY AS EPIPHENOMENON OF CARDIOTOXICITY IN CANCER PATIENTS: A META SUMMARY OF CASE REPORTS 117
Smartphone and new tools for Atrial Fibrillation diagnosis: evidence for clinical applicability 117
Echocardiography in Cardiac Arrest: Incremental Diagnostic and Prognostic Role during Resuscitation Care 116
Echocardiography in the Ventilated Patient: What the Clinician Has to Know 116
Ventricular fibrillation induced by coagulating mode bipolar electrocautery during pacemaker implantation in Myotonic Dystrophy type 1 patient. 116
Anti-arrhythmic properties of non-antiarrhythmic medications 116
COVID-19 Myocarditis: Prognostic Role of Bedside Speckle-Tracking Echocardiography and Association with Total Scar Burden 115
Atrial Septal Aneurysms and Supraventricular Arrhythmias: The Role of Atrial Electromechanical Delay. 115
Clinical Performance of Apixaban vs. Vitamin K Antagonists in Patients with Atrial Fibrillation Undergoing Direct Electrical Current Cardioversion: A Prospective Propensity Score-Matched Cohort Study 115
The prognostic role of interatrial block among COVID-19 patients hospitalized in medicine wards 115
Put out the fire: The pleiotropic anti-inflammatory action of non-vitamin K oral anticoagulants 114
Arrhythmogenic syncope leading to cardiac rhythm management procedures during COVID-19 lockdown 114
Giant coronary sinus in patient with double superior vena cava demonstrated by multislice computed tomography 113
Impact on All-Cause and Cardiovascular Mortality of Cardiac Implantable Electronic Device Complications: Results From the POINTED Registry 113
Asystole on loop recorder in patients with unexplained syncope and negative tilt testing: age distribution and clinical predictors 112
The role of multimodality imaging in athlete’s heart diagnosis: Current status and future directions 112
111Ag phantom images with Cerenkov Luminescence Imaging and digital autoradiography within the ISOLPHARM project 110
Assessment of the Effectiveness of Ticagrelor Preloading in Mitigating Periprocedural Myocardial Injury Among Non-ST Elevation Myocardial Infarction Patients Opting for an Early Invasive Approach 110
Takotsubo Syndrome and Oxidative Stress: Physiopathological Linkage and Future Perspectives 110
Severe obesity and P-wave dispersion: the effect of surgically induced weight loss. 110
Cardioinhibitory syncope with asystole during nitroglycerin potentiated head up tilt test: prevalence and clinical predictors 110
Comprehensive Cardiovascular Management of Myotonic Dystrophy Type 1 Patients: A Report from the Italian Neuro-Cardiology Network 109
Increased dispersion of ventricular repolarization in emery dreifuss muscular dystrophy patient 108
Cardiovascular comorbidities and pharmacological treatments of covid-19 patients not requiring hospitalization 107
Migration of long-sensing vector implantable loop recorder unmasked by remote monitoring in patient with unexplained syncope 107
Bachmann bundle pacing reduces atrial electromechanical delay in type 1 myotonic dystrophy patients 106
Safety and Efficacy of Triple Antithrombotic Therapy with Dabigatran versus Vitamin K Antagonist in Atrial Fibrillation Patients: A Pilot Study 106
Prevalence and clinical predictors of vasodepressor syncope during head up tilt test 105
Insulin resistance and cancer: molecular links and clinical perspectives 105
Serum Lipids, Inflammation, and the Risk of Atrial Fibrillation: Pathophysiological Links and Clinical Evidence 105
Totale 12.937
Categoria #
all - tutte 125.423
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.423


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.350 0 18 34 46 395 4 8 33 39 145 199 429
2022/20232.500 256 29 38 180 235 172 9 110 1.374 28 37 32
2023/20241.110 70 39 50 64 448 51 44 19 11 29 78 207
2024/20255.241 30 46 19 68 752 664 447 447 757 1.086 452 473
2025/202621.838 915 1.133 1.331 1.212 1.705 11.710 1.264 814 883 377 302 192
2026/2027647 213 434 0 0 0 0 0 0 0 0 0 0
Totale 34.896